36.17

1.06% 0.38

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $36.17, with a volume of 269.65K. It is up +1.06% in the last 24 hours and up +29.50% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Previous Close:

$35.79

Open:

$36.14

24h Volume:

269.65K

Relative Volume:

0.49

Market Cap:

$1.75B

Revenue:

$447.57M

Net Income/Loss:

$-38.92M

P/E Ratio:

-66.98

EPS:

-0.54

Net Cash Flow:

$-1.15M

1W Performance:

+0.39%

1M Performance:

+29.50%

6M Performance:

+55.97%

1Y Performance:

-13.88%

1-Day Range:

$35.91

$36.47

1-Week Range:

$34.93

$36.70

52-Week Range:

$18.94

$42.98

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1200)

Industry

Medical Instruments & Supplies (58)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,200

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	36.17	1.75B	447.57M	-38.92M	-1.15M	-0.54
ISRG Intuitive Surgical Inc	538.55	192.83B	7.87B	2.24B	586.00M	4.25
BDX Becton Dickinson Co	221.98	64.77B	20.18B	1.73B	3.07B	5.51
ALC Alcon Inc	88.23	43.75B	9.76B	1.16B	665.00M	0.72
RMD Resmed Inc	249.33	36.84B	4.81B	1.11B	1.35B	6.16
WST West Pharmaceutical Services Inc	323.32	23.33B	2.88B	499.60M	321.60M	7.41

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

Nov 24, 2024

BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $14.04 Million Stake in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Nov 24, 2024

Connor Clark & Lunn Investment Management Ltd. Buys 52,533 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Nov 24, 2024

B. Metzler seel. Sohn & Co. Holding AG Purchases Shares of 31,366 AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Nov 24, 2024

Nov 21, 2024

Trend Tracker for (ATRC) - Stock Traders Daily

Nov 21, 2024

Nov 20, 2024

AtriCure Inc. loses $24 million in value following the election (See how it affected others) - The Business Journals

Nov 20, 2024

AtriCure to Present at Piper Sandler Healthcare Conference in December | ATRC Stock News - StockTitan

Nov 20, 2024

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference - Business Wire

Nov 20, 2024

AtriCure, Inc. (NASDAQ:ATRC) Receives $43.11 Average Price Target from Analysts - MarketBeat

Nov 20, 2024

What to Expect from AtriCure - AOL

Nov 20, 2024

Nov 19, 2024

Assetmark Inc. Has $39,000 Position in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Nov 19, 2024

Nov 14, 2024

Hood River Capital Management LLC Bolsters Stake in AtriCure Inc. - GuruFocus.com

Nov 14, 2024

A Piece Of The Puzzle Missing From AtriCure, Inc.'s (NASDAQ:ATRC) 28% Share Price Climb - Simply Wall St

Nov 06, 2024

Nov 05, 2024

AtriCure (ATRC) Stock Surges Over 5% Amid Market Volatility - GuruFocus.com

Nov 05, 2024